Table 3.
Multivariable regression analysis for predictors of continence 1 month following RARP
| Multivariable OR (95% CI) | p value | |
|---|---|---|
| Age (continuous) | 0.95 (0.91, 0.98) | 0.012 |
| BMI (continuous) | 0.965 (0.91, 1.02) | 0.229 |
| Preoperative PSA (continuous) | 1.019 (0.98, 1.06) | 0.377 |
| Prostate weight (continuous) | 0.996 (0.98, 1.01) | 0.620 |
| Preoperative IPSS (Mild [0–7] as referent) | ||
| Moderate (8–19) | 0.549 (0.32, 0.93) | 0.027 |
| Severe (20–35) | 0.745 (0.26, 2.12) | 0.581 |
| Preoperative SHIM (No ED [22–25] as referent) | ||
| Mild (17–21) | 0.888 (0.49, 1.62) | 0.698 |
| Mild to moderate (12–16) | 1.468 (0.66, 3.29) | 0.35 |
| Moderate (8–11) | 0.285 (0.06, 1.45) | 0.131 |
| Severe (1–7) | 0.816 (0.36, 1.87) | 0.631 |
| Nerve-sparing (None as referent) | ||
| Unilateral | 0.655 (0.3, 1.44) | 0.291 |
| Bilateral | 1.114 (0.59, 2.1) | 0.738 |
| pStage ≥ pT3a (pT2 as referent) | 1.093 (0.64, 1.87) | 0.744 |
RARP: robot-assisted radical prostatectomy; OR: odds ratio; CI: confidence interval; IPSS: International prostate symptom score; PSA: prostate-specific antigen; SHIM: sexual health inventory for men; ED: erectile dysfunction.